Journal article

Achievements and obstacles of remyelinating therapies in multiple sclerosis

Martin Stangel, Tanja Kuhlmann, Paul M Matthews, Trevor J Kilpatrick

Nature Reviews Neurology | NATURE PUBLISHING GROUP | Published : 2017


Awarded by German Research Foundation

Awarded by Interdisciplinary Clinical Research Center, Munster (IZKF)

Funding Acknowledgements

This study was supported by grants to T.K. from the German Research Foundation (SFB-TR128-B7; Ku1477/6-1) and the Interdisciplinary Clinical Research Center, Munster (IZKF; KuT3/012/15). P.M.M. is in receipt of personal and research support from the Edmond J. Safra Foundation and Lily Safra, the Imperial College National Institute for Health Research (NIHR) Biomedical Research Centre, the NIHR Senior Investigator Programme, the UK Dementia Research Institute, the UK Medical Research Council, Biogen and the Engineering and Physics Science Research Council. M.S. is supported by Niedersachsen Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony.